Cystic Fibrosis

March 17, 2017March 17, 2017

Aeolus Pharmaceuticals’ AEOL 20415 Protected Lungs Against Infection in CF Animal Model

Cystic Fibrosis, News

Results from a new animal study show that Aeolus Pharmaceuticals’ anti-microbial compound, AEOL 20415, may protect the lungs from infections in cystic fibrosis (CF). In the study, conducted in a ... Read more

March 15, 2017March 15, 2017

CF Life Expectancy in Canada Is 10 Years Longer Than in US, Study Finds

Cystic Fibrosis, News

People with cystic fibrosis (CF) who live in Canada can statistically anticipate living about 10 years longer than CF patients with similar demographics and disease profiles living in the U.S., ... Read more

March 9, 2017March 9, 2017

Vertex Acquires Potential CF Therapy, CTP-656, a Deuterium-Modified Form of Kalydeco

Cystic Fibrosis, News

Vertex Pharmaceuticals has signed a $160 million purchase agreement to acquire CTP-656, a potential treatment for cystic fibrosis (CF), from Concert Pharmaceuticals. The agreement covers development and marketing rights worldwide. ... Read more

March 7, 2017March 7, 2017

Treatment Seen to Lessen Fibrotic Scarring That Causes Lung Transplants to Fail

Bronchiolitis, COPD, Cystic Fibrosis, Idiopathic Pulmonary Fibrosis, News

Treatment may be able prevent the progressive accumulation of scar tissue (fibrosis) in newly transplanted lungs that eventually cause those organs to fail, researchers at the University of Michigan report. The study, “Autocrine lysophosphatidic ... Read more

March 2, 2017March 2, 2017

Class of IV Antibiotics for Lung Infections Tied to Risk of Hearing Loss in CF Patients

Cystic Fibrosis, News

A class of antibiotics commonly used by people with cystic fibrosis (CF) was found to significantly increase the risk of permanent hearing loss in these patients when given at high dosages ... Read more

February 13, 2017February 13, 2017

P-PAL Device Offers Hope for Kids with CF, Others Awaiting Lung Transplants

Cystic Fibrosis, News

Pittsburgh researchers are building a device for children with lung failure that will replace traditional oxygenation methods while waiting for a transplant. The Pittsburgh Pediatric Ambulatory Lung (P-PAL), being developed ... Read more

February 8, 2017February 8, 2017

Does Viewing Informational Video Blogs Engage Patients? Results Say Yes

Cystic Fibrosis, News

Online video blogs, also known as vlogs, can be a useful tool to educate and inform people about specific medical conditions, including lung diseases, and can help both doctors and their ... Read more

February 6, 2017February 6, 2017

International Experts Update Guidelines for Cystic Fibrosis Diagnosis

Cystic Fibrosis, News

An international group of experts has updated the guidelines for the definite diagnosis of cystic fibrosis (CF), which will help clinicians make a correct diagnoses and offer personalized therapies to their ... Read more

January 24, 2017January 24, 2017

FDA Grants Orphan Drug Status to Concert’s Cystic Fibrosis Therapy Candidate

Cystic Fibrosis, News

The U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation to Concert Pharmaceuticals’ CTP-656 (deuterium-modified ivacaftor), a next generation CFTR (cystic fibrosis transmembrane conductance regulator) potentiator which is being developed for ... Read more

January 12, 2017January 12, 2017

CFF Therapeutics Awards Aridis Grant to Advance Therapy for Lung Infections

Cystic Fibrosis, News

Cystic Fibrosis Foundation Therapeutics (CFFT), the drug discovery and development affiliate of the Cystic Fibrosis Foundation (CFF), has awarded Aridis Pharmaceuticals a grant to support the clinical development of Panaecin (gallium ... Read more